When validated with another microarray data set, we found that the alteration in MYH6 expression was lower in CAD patients than in healthy controls, lower in AMI patients than in healthy controls, lower in CAD patients than in AMI patients and lower in HF patients than in non‐HF patients. Here, MYH6 is linked to coronary artery disorder.